ACTIVE

ORTHOSPINE

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-95,1 k €+78,7 %over 1 year

Revenue46,1 k €-97,3 %over 1 year

Equity-232,8 k €-69,0 %over 1 year

Workforce12,1 ETP-16,6 %over 1 year

Identity

Source · BCE/KBO

ORTHOSPINE is a Public limited company incorporated in 1968. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Mechelen. It employs on average 12,1 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0403.015.402
Incorporation: 01/01/1968
Legal form: Public limited company
Registered office: Vaartdijk 90
2800 Mechelen · FlandreSee on map
Contributed capital: 574 438,00 €
Latest accounts: 31/12/2025
Average workforce: 12,1 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 51460Air transport

Joint committees (3)

Signals

Positive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 15 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	46,1 k €	-97.3%	1,7 M €	-37.7%	2,8 M €	-93.2%	41 M €	-14.9%	48,2 M €
EBITDA	15,2 k €	+103%	-517,4 k €	-251%	-147,3 k €	-141%	361,5 k €	+314%	-168,7 k €
Operating result	-87,5 k €	+79.2%	-420,2 k €	-74.9%	-240,2 k €	+94.6%	-4,4 M €	-487%	-750,9 k €
Net result	-95,1 k €	+78.7%	-446,5 k €	-175%	-162,6 k €	+96.5%	-4,7 M €	-357%	-1 M €
Balance sheet
Equity	-232,8 k €	-69.0%	-137,8 k €	-145%	308,7 k €	-91.6%	3,7 M €	-56.0%	8,4 M €
Total assets	267,4 k €	-79.2%	1,3 M €	-43.3%	2,3 M €	-89.2%	21 M €	-19.6%	26,1 M €
Cash	67,6 k €	-56.8%	156,3 k €	+146%	63,5 k €	-95.8%	1,5 M €	+3344%	43,5 k €
Debts	403,6 k €	-71.7%	1,4 M €	-27.3%	2 M €	-87.8%	16,1 M €	-9.0%	17,7 M €
Other
Workforce	12,1 ETP	-16.6%	14,5 ETP	-68.1%	45,5 ETP	-47.0%	85,8 ETP	-3.1%	88,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

5 active · 16 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Diogo Santos de Lima	Director12/12/2025 → 17/04/2031
Lana Gybels	Director12/12/2025 → 17/04/2031
D&Q FINEXPERTS0667.576.566Represented by Kristof Marivoet	Director28/02/2024 → 28/02/2030
FH IMPACT MANAGEMENT0797.340.691Represented by Frédéric Hoffmann	Director28/02/2024 → 28/02/2030
LEVICO0881.737.522Represented by Geert Kuys	Director07/09/2023 → 07/09/2029

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Duo-Med BidCo B.V.Represented by Kristof Marivoet	Director25/05/2022 → 2024 accounts
R.E. van der List	Director25/05/2022 → 2024 accounts

Other companies at this address

Vaartdijk 90 2800 Mechelen

Company	CBE no.
AMISTA● Active	0555.993.013
Anchr Holdings Europe● Active	0794.652.209
ANCHR LEGAL & GRC● Active	1039.132.888
Ando Group● Active	0778.297.019
ANROVA SOLUTIONS● Active	0724.841.705
AXI● Active	0407.653.980
Blents● Active	0715.808.332
BLUEBITS● Active	0812.125.669
DUOMA INVEST● Active	1014.000.782
GeONE Belgium● Active	0743.861.623
GP DUOMA● Active	1013.858.450
Legile● Active	0737.870.189
NESSI● Active	0631.880.566
NESSI HOLDING● Active	0630.676.677
NESSI TECH● Active	0682.474.182
Palex Belgium● Active	0416.834.437
Palex Healthcare Group Belgium● Active	0628.963.836
Palex Healthcare Group North and Central Europe● Active	1007.767.345
Stichting Future 5bis● Active	1010.954.586

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	06/07/2026	28/07/2025	26/09/2024	28/08/2023	23/05/2022	27/04/2021
General meeting	29/06/2026	30/06/2025	23/09/2024	30/06/2023	21/04/2022	15/04/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	29/06/2026	06/07/2026	Dutch	PDF
Full model	31/12/2024	30/06/2025	28/07/2025	Dutch	PDF
Full model	31/12/2023	23/09/2024	26/09/2024	Dutch	PDF
Full model	31/12/2022	30/06/2023	28/08/2023	Dutch	PDF
Full model	31/12/2021	21/04/2022	23/05/2022	Dutch	PDF
Full model	31/12/2020	15/04/2021	27/04/2021	Dutch	PDF
Full model	31/12/2019	18/06/2020	08/07/2020	French	PDF
Full model	31/12/2018	20/06/2019	01/07/2019	French	PDF
Full model	31/12/2017	21/06/2018	27/06/2018	French	PDF
Full model	31/12/2016	15/06/2017	23/06/2017	French	PDF
Full model	31/12/2015	11/08/2016	12/08/2016	French	PDF
Full model	31/12/2014	18/06/2015	07/07/2015	French	PDF
Full model	31/12/2013	19/06/2014	14/07/2014	French	PDF
Full model	31/12/2012	20/06/2013	18/07/2013	French	PDF
Full model	31/12/2011	21/06/2012	03/07/2012	French	PDF
Full model	31/12/2010	16/06/2011	12/07/2011	French	PDF
Full model	31/12/2009	17/06/2010	19/07/2010	French	PDF
Full model	31/03/2009	25/09/2009	12/10/2009	French	PDF
Full model	31/03/2008	12/03/2009	17/03/2009	French	PDF
Full model	31/03/2007	14/12/2007	21/05/2008	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

5 active · 16 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Diogo Santos de Lima	Director12/12/2025 → 17/04/2031
Lana Gybels	Director12/12/2025 → 17/04/2031
D&Q FINEXPERTS0667.576.566Represented by Kristof Marivoet	Director28/02/2024 → 28/02/2030
FH IMPACT MANAGEMENT0797.340.691Represented by Frédéric Hoffmann	Director28/02/2024 → 28/02/2030
LEVICO0881.737.522Represented by Geert Kuys	Director07/09/2023 → 07/09/2029

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Duo-Med BidCo B.V.Represented by Kristof Marivoet	Director25/05/2022 → 2024 accounts
R.E. van der List	Director25/05/2022 → 2024 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Registered office11/05/2026
MAATSCHAPPELIJKE ZETEL
PDF
Mandates08/01/2026
KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Mandates08/01/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates21/06/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/11/2023
ONTSLAGEN - BENOEMINGEN
PDF
Restructuring31/07/2023
BENAMING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring09/05/2023
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Restructuring23/03/2023
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...) - DIVERSEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings15 filings

Mandates

Diogo Santos de Lima

Lana Gybels

D&Q FINEXPERTS

FH IMPACT MANAGEMENT

LEVICO

Duo-Med BidCo B.V.

R.E. van der List

Ewoud Welten

The Surgical Company BV (32083375)

The Surgical Company Holding bv (32083375)

Jan Willem Elemans

Peter De Jong

Show the 9 other mandates

1968196919701971197219731974197519761977197819791980198119821983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028202920302031

ORTHOSPINE

Lenniksebaan 451, 1070 Anderlecht

Director

Managing director

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Vaartdijk 90, 2800 MechelenCurrent		CBE
Lenniksebaan 451, 1070 Anderlecht	accounts 2021 → 2025	Accounts 2025 · 2026-00264392

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
ORTHOSPINECurrent	accounts 2022 → 2025	Accounts 2025 · 2026-00264392
Hospithera	accounts 2021	Accounts 2021 · 2022-20033415

Events

2025
Annual accounts 2025-95,1 k €↑
2024
Annual accounts 2024-446,5 k €↓
2023
Annual accounts 2023-162,6 k €↑
2022
Annual accounts 2022-4,7 M €↓
2022
Name changeORTHOSPINE
2021
Annual accounts 2021-1 M €↓
2020
Annual accounts 20201,3 M €↑
2017
Annual accounts 2017375 k €↓
2016
Annual accounts 2016412,9 k €↑
2014
Annual accounts 2014318,1 k €↓
2013
Annual accounts 2013338,8 k €↓
2012
Annual accounts 2012404,5 k €↓
2010
Annual accounts 2010471,7 k €↓
2009
Annual accounts 2009566,9 k €↓
2009
Annual accounts 20091,3 M €↑
2008
Annual accounts 2008273 k €
01/01/1968
IncorporationPublic limited company

ORTHOSPINE

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events